1. Home
  2. FAMI vs ASBP Comparison

FAMI vs ASBP Comparison

Compare FAMI & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

BUY

Current Price

$1.44

Market Cap

7.8M

ML Signal

BUY

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$1.92

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
ASBP
Founded
2015
2021
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
7.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
FAMI
ASBP
Price
$1.44
$1.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
600.1K
1.3M
Earning Date
08-04-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,831,754.00
$1,941.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$1.66
52 Week High
$3.64
$632.00

Technical Indicators

Market Signals
Indicator
FAMI
ASBP
Relative Strength Index (RSI) 55.87 85.41
Support Level $1.11 $0.05
Resistance Level $1.43 $2.45
Average True Range (ATR) 0.14 0.10
MACD 0.02 0.22
Stochastic Oscillator 79.09 77.86

Price Performance

Historical Comparison
FAMI
ASBP

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: